These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19545)

  • 1. Platelet-aggregating factor and the aggregation of fixed washed platelets.
    Cooper HA; Wilkins KW; Johnson PR; Wagner RH
    J Lab Clin Med; 1977 Sep; 90(3):512-21. PubMed ID: 19545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density.
    Pipili E
    Thromb Haemost; 1985 Oct; 54(3):645-9. PubMed ID: 2418525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin.
    Kao KJ; Shaut DM; Klein PA
    Thromb Haemost; 1986 Feb; 55(1):136-42. PubMed ID: 3705001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of aggregated immunoglobulins to the human platelet Fc receptors: a mechanism of platelet to platelet bridging.
    Parbtani A; Clark WF; Caveney A; Reid B
    Thromb Haemost; 1987 Dec; 58(4):966-70. PubMed ID: 3127922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deaggregation of in vitro-degranulated human platelets: irreversibility of aggregation may be agonist-specific rather than related to secretion per se.
    Bauman JE; Reimers HJ; Joist JH
    Thromb Haemost; 1987 Oct; 58(3):899-904. PubMed ID: 3433252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma.
    Pfueller SL; Weber S; Lüscher EF
    J Immunol; 1977 Feb; 118(2):514-24. PubMed ID: 557068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evans blue: a specific inhibitor of factor VIII-induced platelet agglutination.
    Kirby EP
    Thromb Diath Haemorrh; 1975 Dec; 34(3):770-9. PubMed ID: 1239827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
    Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
    Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deaggregation of human platelets aggregated by thrombin.
    Kinlough-Rathbone RL; Perry DW; Packham MA; Mustard JF
    Thromb Haemost; 1985 Feb; 53(1):42-4. PubMed ID: 2986309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of bovine factor VIII with human platelets.
    Kirby EP; Mills DC
    J Clin Invest; 1975 Aug; 56(2):491-502. PubMed ID: 807600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation.
    Krishnamurthi S; Westwick J; Kakkar VV
    Thromb Haemost; 1982 Oct; 48(2):136-41. PubMed ID: 6891107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.
    Henson PM
    J Clin Invest; 1977 Aug; 60(2):481-90. PubMed ID: 874106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin receptor occupancy modulates aggregation efficiency and platelet surface expression of vWF and thrombospondin at low thrombin concentrations.
    Kasirer-Friede A; Legrand C; Frojmovic MM
    Thromb Haemost; 1999 Jun; 81(6):967-75. PubMed ID: 10404777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.